![]() |
RELATED RESOURCES |
SEC Filings:ENZNENZON PHARMACEUTICALS INC0.3275
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2020 | Form 8-K* | Current Report* | 12/21/2020 | 12/18/2020 |
Form 424B3 | Prospectus | 11/24/2020 | N/A | |
Form EFFECT | Notice of Effectiveness | 11/23/2020 | N/A | |
Form 4 | Insider Transaction | 11/18/2020 | 11/16/2020 | |
Form 4 | Insider Transaction | 11/17/2020 | 11/13/2020 | |
Form S-1 | Registration General Form | 11/12/2020 | N/A | |
Form 10-Q* | Quarterly Report* | 11/09/2020 | 09/30/2020 | |
Form DEF 14A | Definitive Proxy Statements | 11/03/2020 | 12/18/2020 | |
Form DEFA14A | Definitive Proxy Statements | 11/03/2020 | N/A | |
Form 4 | Insider Transaction | 10/14/2020 | 10/09/2020 | |
Form 8-K* | Current Report* | 10/14/2020 | 10/09/2020 | |
Form SC 13D/A | Acquistion of beneficial ownership | 10/14/2020 | N/A | |
Form 8-K* | Current Report* | 09/23/2020 | 09/21/2020 | |
Form 424B3 | Prospectus | 09/23/2020 | N/A | |
Form EFFECT | Notice of Effectiveness | 09/21/2020 | N/A |